Head-to-head dispatch
NexLife vs Trimi
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).
Marked down on: State availability not publicly disclosed
FDAWarning letter issued to Nexlife Inc. dba Nexlife in June 2026. See the FDA warning-letter database.
Desk Score
Both molecules on one membership at a keen flat price, shipped free to all 50 states.
Marked down on: Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
Trimi takes this head-to-head with the higher Desk Score, 84/100 (B) against 62/100 (C) for NexLife. NexLife still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
NexLife
62/100
C
Trimi
84/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | NexLife | Trimi |
|---|---|---|
| Semaglutide | $165/mo (compounded) | $175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge) |
| Tirzepatide | $215/mo (compounded) | $235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge) |
| Coverage | Coverage not published | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Readers who want pharmacy-quality-conscious patients seeking LegitScript + NABP-certified compounded GLP-1. | Cost-first patients who want both molecules at the cheapest sticker price and don't need brand-name or oral routes. |
| Desk Score | 62/100C | 84/100B |
The verdict
Desk pick — TrimiTrimi takes this head-to-head with the higher Desk Score, 84/100 (B) against 62/100 (C) for NexLife. NexLife still holds its ground where its strengths line up with yours.
Choose NexLife if…
Readers who want pharmacy-quality-conscious patients seeking LegitScript + NABP-certified compounded GLP-1.
$165/mo (compounded) sema · $215/mo (compounded) tirz · Coverage not published
FDAWarning letter issued to Nexlife Inc. dba Nexlife in June 2026. See the FDA warning-letter database.
Choose Trimi if…
Cost-first patients who want both molecules at the cheapest sticker price and don't need brand-name or oral routes.
$175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge) sema · $235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge) tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: NexLife · Trimi.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- NexLife vs CoreAge Rx
- Trimi vs Vaylen
- NexLife vs Strut Health
- Trimi vs Ondra Health
- NexLife vs Invigor Medical
- Trimi vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.